The safety of recombinant factor VIIa: a rebuttal

被引：3
|
作者：
Teitel, J
Poon, MC
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Foothills Prov Gen Hosp, Calgary, AB T2N 2T9, Canada
[4] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 11期
关键词：
D O I：
10.1111/j.1538-7836.2004.00974.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2078 / 2078
页数：1
相关论文
共 50 条
  • [41] Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity - a rebuttal
    Sallah, S
    Isaksen, M
    Seremetis, S
    Rojkjaer, LP
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 820 - 822
  • [42] Updated Post-Licensure Safety Surveillance for Recombinant Human Coagulation Factor VIIa
    Ou, Alan C.
    Jain, Nisha
    Maplethorpe, Charles W.
    Wise, Robert P.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S187 - S188
  • [43] Treatment of factor VII deficiency with recombinant factor VIIa
    Bauer, KA
    [J]. HAEMOSTASIS, 1996, 26 : 155 - 158
  • [44] Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia
    Al Hammadi, A. M.
    Sallah, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (02) : 435 - 436
  • [45] Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage
    Caram-Deelder, Camila
    McKinnon Edwards, Hellen
    Zdanowicz, Jarmila A.
    van den Akker, Thomas
    Birkegard, Camilla
    Blatny, Jan
    van der Bom, Johanna G.
    Colucci, Giuseppe
    van Duuren, Derek
    van Geloven, Nan
    Henriquez, Dacia D. C. A.
    Knight, Marian
    Korsholm, Lars
    Landorph, Andrea
    Lavigne Lissalde, Geraldine
    McQuilten, Zoe K.
    Surbek, Daniel
    Wellard, Cameron
    Wood, Erica M.
    Mercier, Frederic J.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [46] Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity - reply to a rebuttal
    Aledort, LM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 822 - 822
  • [47] Thrombosis and Recombinant Factor VIIa: Letter 1
    DeAnda, Abe, Jr.
    Hymes, Kenneth
    [J]. ANNALS OF THORACIC SURGERY, 2012, 94 (05): : 1783 - 1783
  • [48] Use of recombinant factor VIIa in massive hemorrhage
    Baranovic, S.
    Rakaric-Poznanovic, M.
    [J]. NEUROLOGIA CROATICA, 2004, 53 : 109 - 112
  • [49] Factor VIIa (recombinant) for acute traumatic hemorrhage
    Patanwala, Asad E.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (17) : 1616 - 1623
  • [50] Recombinant Factor VIIa : A Universal Haemostatic Agent?
    Gill, Ravi
    [J]. ANNALS OF CARDIAC ANAESTHESIA, 2006, 9 (02) : 97 - 99
12345